Gray matter networks and clinical progression in subjects with predementia Alzheimer's disease

Research output: Contribution to journalArticleAcademicpeer-review

40 Citations (Scopus)


We studied whether gray matter network parameters are associated with rate of clinical progression in nondemented subjects who have abnormal amyloid markers in the cerebrospinal fluid (CSF), that is, predementia Alzheimer's disease. Nondemented subjects (62 with subjective cognitive decline; 160 with mild cognitive impairment (MCI); age = 68 ± 8 years; Mini-Mental State Examination (MMSE) = 28 ± 2.4) were selected from the Amsterdam Dementia Cohort when they had abnormal amyloid in CSF (<640 pg/mL). Networks were extracted from gray matter structural magnetic resonance imaging (MRI), and 9 parameters were calculated. Cox proportional hazards models were used to test associations between each connectivity predictor and rate of progression to MCI or dementia. After a median time of 2.2 years, 122 (55%) subjects showed clinical progression. Lower network parameter values were associated with increased risk for progression, with the strongest hazard ratio of 0.29 for clustering (95% confidence interval = 0.12-0.70; p < 0.01). Results remained after correcting for tau, hippocampal volume, and MMSE scores. Our results suggest that at predementia stages, gray matter network parameters may have use to identify subjects who will show fast clinical progression.

Original languageEnglish
Pages (from-to)75-81
Number of pages7
JournalNeurobiology of aging
Publication statusPublished - Jan 2018


  • Aged
  • Alzheimer Disease/diagnosis
  • Amyloid/cerebrospinal fluid
  • Biomarkers
  • Cognitive Dysfunction/diagnosis
  • Disease Progression
  • Female
  • Gray Matter/diagnostic imaging
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Mental Status and Dementia Tests
  • Middle Aged
  • Organ Size
  • Proportional Hazards Models
  • Risk
  • Time Factors

Cite this